A glycolipid (OO1X) isolated from the membrane proteoglycans of a non-pathogenic strain ofKlebsiellapneumoniae was developed to bind selectively to macrophages. A scintigraphic technique could thus be developed and applied to an experimental model of lung berylliosis. Six baboons were injected intratracheally with a beryllium metal suspension. Three to 24 months later, they were submitted to both an anatomical and a functional respiratory evaluation. Two baboons were explored at the early stage of alveolitis and four baboons at a more advanced stage characterised by a granulomatous disorder. Scintigraphy was performed using JOOlX labelled with 'mtechnetium administered as an aerosol.
with 'mtechnetium administered as an aerosol.
In the six baboons, conventional imaging techniques (chest x ray film, computed tomography scan, gavllium scintigraphy), failed to show either any lung abnormality or mediastinal lymph nodes consistent with beryllium disease. In the two recently contaminated baboons, JOOlX scintigraphy showed a well defined parenchymal fixation facing the contaminated lobe. In the four baboons who were at a more advanced stage of berylliosis, JOOlX fixation was always focused paratracheally without any significant involvement ofthe lung parenchyma. The subcarinal and laterotracheal lymph nodes seen at necropsy corresponded to JOOlX scintigraphic fixations. In conclusion, when compared with conventional techniques such as chest x ray film, computed tomography scan, magnetic resonance imaging, and gallium scintigraphy, JOOlX scintigraphy has proved its ability to detect occult lesions in experimental berylliosis in baboons. By comparison with gallium scintigraphy, scintigraphy with JOOlX appears to have superior sensitivity and can be performed in four hours.
Beryllium is a light metal with physicochemical characteristics (high melting point, low density, high modulus of elasticity, low coefficient of thermal expansion) that has led to an extensive use in modem industries such as the space programme and nuclear power (electrical energy, military, and medical applications).'2 Through a direct irritant effect of the metal, acute exposure to beryllium may lead to an inflammation of the mucous membranes and the respiratory tract. Chronic berylliosis is a systemic granulomatous disease that primarily affects the lungs. As (fig 1) . Using a 'Tc oseophageal scintigraphy, the JOO1X fixation was differentiated from an oesophageal tract contamination occurring during the inhalation. No necropsy was performed at that time to allow the study of the evolution of the pathology.
Baboon 342 was investigated three months after beryllium contamination. At that stage, no thoracic abnormality was evident on chest x ray film. From one to five hours after inhalation, JOO1X scintigraphy showed a localised fixation that projected on the right lower lobe. At necropsy, histological samples showed a severe alveolitis in the right lower lobe without parenchymal granuloma or mediastinal lymph nodes.
Baboon 482 was investigated monthly from six to 18 months after contamination. No thoracic abnormality was evident on chest x ray film, computed tomography scan, and magnetic resonance imaging. JOOIX scintigraphy disclosed a focal fixation on the right side of the trachea (fig 2) . A residual digestive activity was excluded using 9'9technetium oesophageal scintigraphy. At the necropsy, two enlarged lymph nodes, 10 x 4 mm in size, were found on the right side ofthe trachea and under the carina, without any specific parenchymal feature.
Baboon 433 scintigraphy showed localised right laterotracheal fixation. This focus appeared five hours after JOO1X inhalation and persisted until the end ofthe examination (seven hours after administration). Based on 9technetium oesophageal scintigraphy, this JOOlX fixation was not related to a digestive contamination.
Baboon 336 was investigated 24 months after beryllium contamination. No thoracic abnormality was evident on chest x ray film and computed tomography scan. JOOIX scintigraphy disclosed a focal fixation located on the right of the trachea. At necropsy, two peritracheal and one subcarinal enlarged lymph nodes were found, about one cm in diameter, associated with histologically confirmed parenchymal granuloma in the right lower lobe.
In summary, recently contaminated baboons (444, 342) showed a JOOIX fixation localised to the contaminated lobe and this fixation corresponded to an alveolitis histologically confirmed in baboon 342. In the four other baboons, contaminated 12 to 24 months before, JOO1X scintigraphy showed mediastinal fixations corresponding to lymph nodes one cm or less in diameter. By contrast, gallium scintigraphy was always negative for all the animals.
Discussion
The early diagnosis of chronic berylliosis remains as yet a clinical problem in industrial medicine. In this study, JOO1X scintigraphy appeared to be efficient for the detection of occult experimental berylliosis via the targeting of macrophages that are involved in the granulomatous process.
In 1930, deaths occurred among workers in the fluorescent lamp industry after beryllium poisoning. 7 The Atomic Energy Commission (AEC) set air standards for beryllium in 1949.8 For workplace air, an eight hour time weighted average maximum permissible level of 2-0 pg/m3 was established. These hygienic standards remain unchanged today and are adequate to prevent many cases of beryllium disease. Nevertheless, long term exposure with a low eight hour time weighted average air concentration or a brief very high exposure could have subclinical effects. So, chronic berylliosis continues to be an important professional lung disease.
Chronic beryllium disease primarily affects the lungs.29 The symptoms appear from a few months to 25 years after the beginning of exposure. The beryllium case registry at the Massachusetts General Hospital has defined criteria for chronic beryllium disease.9 Four of the following six features including one of the two first items are necessary: (1) epidemiological evidence of significant exposure to beryllium; (2) presence of beryllium in lung tissue, lymph nodes, or urine; (3) evidence of a lower respiratory tract disease and a clinical course consistent with beryllium disease; (4) radiological evidence of interstitial disease consistent with a fibronodular process; (5) evidence of a restrictive or obstructive ventilatory defect, or a diminished carbon monoxide diffusing capacity; (6) pathological changes consistent with beryllium disease on examination of lung tissue, or lymph nodes, or both.
In vitro tests were developed for an early diagnosis and a screening of longitudinal epidemiological studies among workers.4"'" Among these, lymphocyte transformation tests are still currently used but little is known about the significance of a positive result.'21 Does it mean a higher risk of disease if the exposure is continuing, or does it act only as a witness of the past exposure? It seems that beryllium exposure, moreover, could have subclinical and reversible effects when followed by a reduction of the exposure.9 So, diagnostic tests are needed to detect early symptoms of respiratory illness.
Alveolar macrophages are the first cells implicated in the immune response triggered by exposure to beryllium:' '6 they take up particulate beryllium compounds by phagocytosis and release lysosomal enzymes. ' The same type of image was obtained with JOOlX in the two recently contaminated baboons: it appeared as a well defined parenchymal fixation that projected to the right lower lobe, the most contaminated part ofthe lung. Clearance ofDTPA, a reference test for the assessment of alveolocapillary permeability,'9 was significantly increased in the whole lung. So, the abnormalities of alveolocapillary permeability induced by beryllium reach the whole lung. By contrast, the anatomical alterations at this early stage of alveolitis appeared in the most contaminated right lower lobe.
In the four baboons who were at a more advanced stage, JOOlX fixation was always focused on the sides of the trachea without any significant involvement of the parenchyma. Mediastinal lymph nodes that were detected on computed tomography scan were less than one cm in diameter and so they could not be considered as a pathological feature."' The subcarinal and laterotracheal lymph nodes found at necropsy in two baboons closely corresponded to the localisation disclosed by JOO1X scintigraphy. On the basis of the scintigraphic similarities, it may be reasonable to argue that the fixations seen in the two nonnecropsied baboons also corresponded to mediastinal lymph nodes. Thus JOO1X scintigraphy could be of value to assess the inflamatory process in thoracic lymph nodes.
In conclusion our data show that JOO1X scintigraphy could be a sensitive indicator to detect occult lung berylliosis both at the stages of early alveolitis and mediastinal berylliotic lymph nodes. This experimental study in baboons has proved its effectiveness when compared with conventional techniques. Further studies including workers exposed to beryllium are necessary to confirm the clinical value of this technique for the follow up of such patients.
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